Trial intelligence / Profile preview

Brain Activation Modulation by Antipsychotics in Schizophrenia

NCT00419653Phase 4Terminated

Sponsor
Friedrich Schiller University Jena
Start
Jan 2003
Primary completion
Sep 2007
Modality
Small Molecules
01

Overview

A Phase 4 trial of amisulpride in schizophrenia, sponsored by Friedrich Schiller University Jena. Started Jan 2003; status: terminated.

02

Drugs

amisulpride
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00419653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00419653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call